type-2

Documents about type-2

• Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets#127814ClinicalTrials.gov
• Metformin Use in Chronic Kidney Disease: The CKD-Met Study#127824ClinicalTrials.gov
• Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.#136240ClinicalTrials.gov
• Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes#136277ClinicalTrials.gov
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM#136281ClinicalTrials.gov
• Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers#140940ClinicalTrials.gov
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression#146293ClinicalTrials.gov
• Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell#146397ClinicalTrials.gov
• The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)#148705ClinicalTrials.gov
• Low-dose IL-2 in Established T1D - The "PROREG" Study#158123ClinicalTrials.gov
• Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.#162426ClinicalTrials.gov
• Diabetes Risk Education and Communication Trial#162432ClinicalTrials.gov
• Heart Rate Variability in Response to Metformin Challenge#172468ClinicalTrials.gov
• To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes#172539ClinicalTrials.gov
• An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .#175049ClinicalTrials.gov
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706#175060ClinicalTrials.gov
• P-type conductivity in Sn-doped Sb₂Se₃#178260Ora Oxford University Research
• Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV#181602ClinicalTrials.gov
• Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy#181714ClinicalTrials.gov
• Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.#181737ClinicalTrials.gov
• Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study.#182663NCBI PubMed Central
• Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models#183842Ora Oxford University Research
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes#18542ClinicalTrials.gov
• Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study#178042HAL (France)
• Early Type 2 diabetes risk prediction using explainable machine learning in a two-stage approach.#908NCBI PubMed Central
• Generation of ALK1 p.Gly48Glu mutant LUMCi029-A-3 for modeling Hereditary hemorrhagic telangiectasia type 2#11604HAL (France)
• 20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up#121502ClinicalTrials.gov
• Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia#123629ClinicalTrials.gov
• Renaming the Extended Sequence Numbers (ESN) Transform Type in the Internet Key Exchange Protocol Version 2 (IKEv2)#131619IETF RFCs
• To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately#136256ClinicalTrials.gov
• Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy#136286ClinicalTrials.gov
• A Comparison of Exenatide and Insulin Glargine#140951ClinicalTrials.gov
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects#143765ClinicalTrials.gov
• Hypoglycaemia Risk Prediction Models for Type 2 Diabetes: A Systematic Review and Meta-Analysis.#145854NCBI PubMed Central
• A Drug Interaction Study of SY-004 Capsules in Healthy Subjects#146354ClinicalTrials.gov
• Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2#146376ClinicalTrials.gov
• Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus#146418ClinicalTrials.gov
• Incretin-based Drugs and the Risk of Heart Failure#148727ClinicalTrials.gov
• Melatonin: a promising therapy to combat type 2 airway inflammation via MT1-Sirt1 pathway.#150356NCBI PubMed Central
• The Influence of Polypharmacy on Type 2 Diabetes Adverse Cardiovascular Outcomes in a Rural Cohort#150427bioRxiv / medRxiv
• Cheeky Cheating or a Sensible Strategy? ‘Sweep Parameters’ in Bucket‐Type Hydrological Models#156296HAL (France)
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes#162332ClinicalTrials.gov
• Bone Marrow Derived Stem Cell Transplantation in T2DM#172527ClinicalTrials.gov
• Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations#175057ClinicalTrials.gov
• Derived equivalence for the simple flop of type $G_2^{\dagger}$ via tilting bundles#179104arXiv (OAI)
• Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D#181712ClinicalTrials.gov
• Insulin Treatment in Diabetic Older People With Heart Failure.#184753ClinicalTrials.gov
• A Rapid and Accurate PCR-Based Method for Mating-Type Determination in the Heterothallic Oomycete Plasmopara viticola , the Causal Agent of Grapevine Downy Mildew#153801HAL (France)
• Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients#156278HAL (France)
• Glycemic Variability Bridges Time in Range and Time in Tight Range: A Unified Equation for Both Type 1 and Type 2 Diabetes Based on Large-Scale Continuous Glucose Monitoring Data.#159797NCBI PubMed Central